Presbycusis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Symmetrical mild to moderately severe hearing loss, with bilateral PTA between 30 and 70 dB HL. 2. Age range: 60–80 years. 3. Primary language: Mandarin Chinese or a regional dialect of Northern China. 4. No prior use of hearing aids at baseline. 5. Patients meeting the WHO criteria for treatable hearing loss.
Exclusion criteria
Exclusion criteria: 1. Patients with severe or profound hearing loss (better-ear PTA >70 dB HL). 2. Individuals with congenital hearing loss or permanent conductive hearing impairment. 3. Asymmetrical hearing loss, defined as an interaural PTA difference >= 30 dB HL. 4. Patients with external auditory canal eczema or otitis externa/media. 5. Individuals with medical contraindications to hearing-aid use (e.g., progressive or fluctuating hearing loss, sudden hearing loss within the past three months, otorrhea, otalgia, vertigo, headache, or congenital/traumatic malformations). 6. Patients with psychiatric disorders, epilepsy, or severe infectious diseases. 7. Individuals unable to comply with study procedures. 8. Participants deemed unsuitable for this clinical trial at the investigator’s discretion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pure-Tone Audiometry;Speech Recognition Score in Quiet;Speech Recognition Score in Noise; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual Analog Scale (VAS) for Subjective Satisfaction; | — |
Countries
China
Contacts
Peking University Third Hospital